TLRY Company Profile and Key Details

Q: Who are the executives of TLRY?

Ms. Nyree PintoChief HR OfficerMr. Bernard Yeung M.B.A.Senior Vice President of Sales & MarketingMr. Mitchell S. GendelGlobal Gen. Counsel & Corporation Sec.Mr. John B. SadlerVice President of Investor RelationsMr. James R. MeiersSenior Vice President of U.S. OperationsMr. Roger SavellChief Admin. Officer & Chief Financial Officer of InternationalMs. Denise Menikheim FaltischekChief Strategy Officer & Head of InternationalMr. Lloyd BrathwaiteChief Information OfficerMr. Bernard YeungSenior Vice President of Sales & MarketingMr. Randy DaigneauSenior Vice President of Supply ChainMr. Cole CacciavillaniSpecial AdvisorMs. Berrin NoorataChief Corporation Affairs OfficerMr. Victor Neufeld CA, CPA, MBASpecial AdvisorMr. Carl A. Merton CA, CBV, CPAChief Financial Officer & Principal Accounting Officer

NASDAQ : TLRY

Tilray Brands

$6.55

0.41+6.68%

At Close 4:00 PM

70.45

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Tilray Brands, Inc. (TLRY) stock surged +6.68%, trading at $6.55 on NASDAQ, up from the previous close of $6.14. The stock opened at $6.04, fluctuating between $5.89 and $6.66 in the recent session.

Stock Snapshot

6.14

Prev. Close

761.28M

Market Cap

5.89

Day Low

-0.45

P/E Ratio

-14.63

EPS (TTM)

-0.07

Cash Flow per Share

6.04

Open

116.23M

Number of Shares

6.66

Day High

99.04%

Free Float in %

4.45

Book Value

5.5M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 02, 2026	6.07	6.66	5.89	6.55	5.5M
Apr 01, 2026	6.61	6.78	6.06	6.14	5.56M
Mar 31, 2026	6.03	6.47	6.03	6.47	3.6M
Mar 30, 2026	6.32	6.40	5.93	5.99	2.75M
Mar 27, 2026	6.54	6.65	6.28	6.32	2.02M
Mar 25, 2026	6.76	7.08	6.75	6.94	2.6M
Mar 24, 2026	6.41	6.72	6.31	6.66	1.6M
Mar 23, 2026	6.25	6.50	6.12	6.45	2.57M
Mar 20, 2026	6.63	6.63	6.15	6.21	3.48M
Mar 19, 2026	6.58	6.71	6.46	6.66	2.35M
Mar 18, 2026	6.90	6.95	6.72	6.73	1.76M
Mar 17, 2026	6.93	7.08	6.86	6.95	1.64M
Mar 16, 2026	6.98	7.09	6.87	6.90	1.6M
Mar 13, 2026	7.00	7.14	6.81	6.89	1.85M
Mar 12, 2026	7.12	7.24	6.93	6.95	2.41M
Mar 11, 2026	7.20	7.45	7.17	7.22	1.97M
Mar 10, 2026	7.36	7.50	7.17	7.20	2.52M
Mar 09, 2026	7.08	7.40	6.83	7.35	3.23M
Mar 06, 2026	6.97	7.30	6.86	7.21	2.68M
Mar 03, 2026	7.40	7.54	7.22	7.36	4.03M

Contact Details

Leamington, ON N8H 5L4

Canada

https://www.tilray.com 120 643 29325

About Company

Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.

Stock Peers

ITCI

Intra-Cellular Therapies, Inc.$131.87 NBIX

-0.96-0.72%

Neurocrine Biosciences, Inc.$131.60 LNTH

0.4+0.53%

Lantheus Holdings, Inc.$76.10 ANIP

-1.75-2.30%

ANI Pharmaceuticals, Inc.$74.21 PAHC

0.76+1.39%

Phibro Animal Health Corporation$55.52 SUPN

-0.96-1.87%

Supernus Pharmaceuticals, Inc.$50.48 HROW

-0.12-0.34%

Harrow Health, Inc.$35.31 COLL

-0.94-2.83%

Collegium Pharmaceutical, Inc.$32.31 PETQ

-0.01-0.03%

PetIQ, Inc.$30.98 RGC

-2.92-8.66%

Regencell Bioscience Holdings Limited$30.80

Company Overview

Tilray Brands, Inc. (NASDAQ:TLRY) closed at $6.55 USD, gaining $0.41 (6.68%) from the previous close of $6.14. The stock is currently mid-range between its 52-week high and low $3.50 and $23.20. With a market capitalization of about $761.28 million, Tilray Brands, Inc. is classified as a small-cap and shows higher-than-market volatility (beta ~2.09). Key stats such as the average daily volume over the past year has been around 3.66 million shares, trading with heavier-than-usual volume. Headquartered in Leamington, ON, Tilray Brands, Inc. operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO Irwin David Simon, the company employs approximately 2,650 people and listed since July 19, 2018. Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally.

Technical Performance

Short-term trend indicators are bullishly aligned (SMA20 4.65%, SMA50 -10.44%, SMA200 -13.75%). The stock’s 14-day RSI is 49.01 (neutral), while the ATR of 0.48 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -65.56% below its high and over 127.83% above its low. Average 10-day trading volume of 3.67 million shares is in line with the 3-month average of 3.62 million, indicating normal recent market interest.

Valuation Metrics

Tilray Brands, Inc. trades at a P/E ratio of -0.38, slightly below the S&P 500 average, with a price-to-sales ratio of 0.69 and a price-to-book ratio of 0.44 suggesting the stock is closer to book value. The P/FCF stands at -8.31, also below market averages.

Dividend & Fair Value

Tilray Brands, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$5.44. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Tilray Brands, Inc. generated EPS of -$22.12 over the past year. Five-year average earnings growth is -62.75%. Wall Street analysts project EPS growth of 87.06% annually over the next five years. The latest quarter delivered EPS of -$0.00. The next quarter is forecast at -$0.14. Next year's EPS is expected at $41.18. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 3 Buy ratings, 2 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $10.00 to $1.00. The high target offers 52.67% upside. The low target suggests -84.73% downside. The mean target is $6.00. This offers -8.4% upside. Tilray Brands, Inc. earnings surprise history is a mixed track record. The quarter that ended October 09, 2025, missed forecasts by -99.27%. The prior quarter beat by -166.67%. Over the last six quarters, Apple has recorded several small beats. These include 100.0% in July 29, 2024.

Shareholding & Insider Activity

Tilray Brands, Inc. has 1.12 billion shares outstanding. The public float is 1.09 billion shares, elevated short interest at 14.82% of float. This equals 161.90 million shares. The short ratio is 1.94 days. Institutional investors hold 11.3% of the float. Insiders own 0.78%. Kennedy Brendan holds 6.22 million shares, SIMON IRWIN D has 3.94 million shares and Merton Carl A has 798.07 thousand shares.

Financial & Profitability Overview

Over the trailing twelve months, Tilray Brands generated $1.13B in revenue, or $12.66 per share. Gross margin was 29.29%, operating margin -277.93%, and net profit margin -266.25%. Returns are negative, with ROA at -103.31% and ROE at -144.68%.
On valuation metrics, Tilray Brands trades at a P/E of -0.38, P/S of 0.69 and P/B of 0.44. The current ratio is 2.79 and quick ratio is 1.66. Operationally, the company’s inventory turnover is 2.73 and cash conversion cycle is 172.50 days. Debt-to-equity is 0.14, supported by a cash flow-to-debt ratio of -0.25.

Quarterly Financial Highlights

For the quarter ended May 31, 2025, Tilray Brands posted revenue of $1.13B, down slightly from $788.94M in the prior quarter. Gross profit was $330.11M (margin 29.29%). Operating income was - $3.13B (margin -277.9%). Net income was- $3.00B (EPS - $33.80).
The company ended the quarter with $351.78M in cash and short-term investments, a total debt of $451.09M, and net debt of $146.92M. Total assets were $2.90B, with equity of $2.04B. Financials further reflected weakness, with operating cash flow of - $129.81M, free cash flow of - $174.98M, and capital expenditures of - $45.17M.

Price Forecast & Outlook

Our AI price prediction model suggests that Tilray Brands, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -12.98%, with price expected at $5.70 by April 16, 2026, within a range of $5.47 to $5.93 3-Month Outlook: Projected fall of -47.79%, reaching $3.42 by July 01, 2026, with a range of $2.86 to $3.95. 1-Year Outlook: Projected gain of 58.47%, with price at $10.38 by April 02, 2027, within a range of $0.00 to $14.48.

Key Takeaways

Tilray Brands, Inc. (NASDAQ:TLRY) shares are flat -3.1% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Tilray Brands, Inc. trading at a premium to the broader market with a P/E of -0.38. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $9.16, suggesting 39.85% upside. Our AI forecast model points to short-term weakness (-12.98% over two weeks), a medium-term fall (-47.79% over three months), and a longer-term gain (58.47% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Tilray Brands, Inc. (TLRY) stock price?

Tilray Brands, Inc. (NASDAQ: TLRY) stock price is $6.55 in the last trading session. During the trading session, TLRY stock reached the peak price of $6.66 while $5.89 was the lowest point it dropped to. The percentage change in TLRY stock occurred in the recent session was 6.68% while the dollar amount for the price change in TLRY stock was $0.41.

TLRY's industry and sector of operation?

The NASDAQ listed TLRY is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Tilray Brands, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of TLRY?

Ms. Nyree Pinto
Chief HR Officer
Mr. Bernard Yeung M.B.A.
Senior Vice President of Sales & Marketing
Mr. Mitchell S. Gendel
Global Gen. Counsel & Corporation Sec.
Mr. John B. Sadler
Vice President of Investor Relations
Mr. James R. Meiers
Senior Vice President of U.S. Operations
Mr. Roger Savell
Chief Admin. Officer & Chief Financial Officer of International
Ms. Denise Menikheim Faltischek
Chief Strategy Officer & Head of International
Mr. Lloyd Brathwaite
Chief Information Officer
Mr. Bernard Yeung
Senior Vice President of Sales & Marketing
Mr. Randy Daigneau
Senior Vice President of Supply Chain
Mr. Cole Cacciavillani
Special Advisor
Ms. Berrin Noorata
Chief Corporation Affairs Officer
Mr. Victor Neufeld CA, CPA, MBA
Special Advisor
Mr. Carl A. Merton CA, CBV, CPA
Chief Financial Officer & Principal Accounting Officer

How TLRY did perform over past 52-week?

TLRY's closing price is 87.14% higher than its 52-week low of $3.50 where as its distance from 52-week high of $23.20 is -71.77%.

How many employees does TLRY have?

Number of TLRY employees currently stands at 2,650.

Link for TLRY official website?

Official Website of TLRY is: https://www.tilray.com

How do I contact TLRY?

TLRY could be contacted at phone 120 643 29325 and can also be accessed through its website. TLRY operates from 265 Talbot Street West, Leamington, ON N8H 5L4, Canada.

How many shares of TLRY are traded daily?

TLRY stock volume for the day was 5.5M shares. The average number of TLRY shares traded daily for last 3 months was 3.66M.

What is the market cap of TLRY currently?

The market value of TLRY currently stands at $761.28M with its latest stock price at $6.55 and 116.23M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	2650
Beta	2.09
Sales or Revenue	$1.13B
5Y Sales Change%	-0.288%
Fiscal Year Ends	May
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

TLRY Company Profile and Key Details

Tilray Brands

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Shareholding & Insider Activity

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Earnings & Analyst Outlook

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook